Skip to main content
Clinical Trials/NCT01370291
NCT01370291
Unknown
Phase 3

Repetitive Transcranial Magnetic Stimulation (rTMS) for First-episode Schizophrenia Patients:A Double-blinded , Randomized and Functional Magnetic Resonance Imaging (fMRI)Study

Xijing Hospital1 site in 1 country60 target enrollmentJune 2011
ConditionsSchizophrenia

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Schizophrenia
Sponsor
Xijing Hospital
Enrollment
60
Locations
1
Primary Endpoint
PANSS
Last Updated
14 years ago

Overview

Brief Summary

The aim of the study is to evaluate the effects of repetitive transcranial magnetic stimulation(rTMS)in the first-episode Schizophrenic patients: the clinical and MRI findings

Registry
clinicaltrials.gov
Start Date
June 2011
End Date
December 2013
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Xijing Hospital
Responsible Party
Principal Investigator
Principal Investigator

fengshufang

Fourth Military Medical University, Department of Psychiatry, Xi Jing hospital

Xijing Hospital

Eligibility Criteria

Inclusion Criteria

  • Age between 16-45 years
  • Diagnosis of schizophrenia according to DSM-IV criteria(by a board-certified psychiatrist)
  • PANSS\>=60
  • First episode, and the patients haven't use any antipsychotic drugs

Exclusion Criteria

  • Suicide risk
  • Diagnose of substance abuse/dependance
  • Severe uncontrolled organic disease that may interfere in the patient´s participation in the study
  • Contraindication to TMS:
  • Implanted pacemaker
  • Medication pump
  • Vagal stimulator
  • Deep brain stimulator
  • Metallic hardware in the head or scalp: shrapnel, surgical clips, or fragments from welding
  • Signs of increased intracranial pressure

Outcomes

Primary Outcomes

PANSS

Time Frame: 1-6 weeks

Secondary Outcomes

  • Total AHRS score(1-6 weeks)
  • HAMD Score(1-6 weeks)
  • CGI(1-6 weeks)
  • fMRI(0,6 week)

Study Sites (1)

Loading locations...

Similar Trials